Skip to main content
Signal8

Adhera Therapeutics Inc (ATRX)

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Sector: Biotechnology

Industry: Biotechnology

Adhera Therapeutics Inc logo

Adhera Therapeutics Inc

OTC:ATRXHealthcare
CLOSED
Mkt Cap-
EV-
Float6.7M
O/S7.22M
VOL20K sh
$ Vol$2
Inst Own-
Net Cash/Sh-
Dilution